PerspectiveAutoimmune Disease

Dissecting the Immune Cell Mayhem That Drives Lupus Pathogenesis

See allHide authors and affiliations

Science Translational Medicine  09 Mar 2011:
Vol. 3, Issue 73, pp. 73ps9
DOI: 10.1126/scitranslmed.3002138

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The autoimmune disease systemic lupus erythematosus (SLE) results from an inability of the immune system to discriminate between certain self-antigens and foreign ones. The most common treatment of SLE involves the use of immunosuppressive drugs to reduce inflammation, but these therapies have serious side effects. Three recent papers in Science Translational Medicine redirect focus on neutrophils, platelets, and interferon-α in the pathogenesis of SLE and reinforce the notion that researchers should seek to discover and devise combination therapies that target these processes.


  • Citation: J. Craft, Dissecting the Immune Cell Mayhem That Drives Lupus Pathogenesis. Sci. Transl. Med. 3, 73ps9 (2011).

View Full Text

Stay Connected to Science Translational Medicine